Advertisement: TTP
Advertisement: partnersand mid banner
Mid banner advertisement: BDO
Advertisement: Wild Knight Vodka
Advertisement: Cambridge Network mid banner
Advertisement: EBCam mid banner
Advertisement: SATAVIA mid banner
Advertisement: Bar Ellison mid banner property
Advertisement: Excalibur Healthcare mid banner
Advertisement: RSM mid banner
Advertisement: Kao Data Centre mid banner
Advertisement: HCR Hewitsons mid banner
Advertisement: Mogrify mid banner
Advertisement: CJBS mid banner
ARM Innovation Hub
Barr Ellison Solicitors – commercial property
Cambridgeand mid banner advertisement
Advertisement: Simpsons Creative
Advertisement: S-Tech mid banner 3
19 April, 2022 - 19:38 By Tony Quested

Cydar and Medtronic fly BioMedTech pilot project

Cambridge surgical augmented intelligence business, Cydar Medical, has agreed a strategic collaboration with Medtronic – an American-Irish global leader in healthcare technology. 

Cydar’s EV Maps software will be introduced at up to 40 new global hospital sites in a pilot scheme. The move combines Cydar’s augmented intelligence technology with Medtronic’s services and case support with the goal of improving patient care.

The software harnesses the latest in cloud GPU computing, computer vision and machine learning technology to advance surgical visualisation and decision-making in theatre and across the care pathway. 

This enables clinicians to create detailed patient-specific 3D maps for procedure planning, image-guided navigation and post-operative review, resulting in less radiation exposure to the patient and the clinical team, reduced procedure time, and increased delivery confidence.

The pilot programme will also inform the future development of predictive analytics to support procedure planning by assessing factors such as the risk of endoleaks, sac regression probability and more.

Medtronic is the first medical technology company to enter a public strategic collaboration in digital endovascular technology to advance aortic patient treatment decisions. The collaboration is part of Medtronic’s ongoing commitment to innovation in aortic care for physicians and their patients.

Carolyn Sleeth, VP, General Manager, Aortic for Medtronic said: “Medtronic aims to revolutionise endovascular aortic treatment with digital solutions with this phased approach.

“By collecting data across the patient journey – before, during and after procedure – our goal is to provide analytic support to make our endovascular stent grafts ‘smart’.” 

Paul Mussenden, CEO of Cydar, added: “By collaborating with Medtronic to bring our Cydar EV Maps solution to up to 40 new hospital sites we are a step closer to achieving our mission to ensure every image-guided endovascular procedure goes exactly as planned.”

Newsletter Subscription

Stay informed of the latest news and features